Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.

Dorjgochoo T, Zheng Y, Gao YT, Ma X, Long J, Bao P, Zhang B, Wen W, Lu W, Zheng W, Shu XO, Beeghly-Fadiel A.

Cancer Epidemiol. 2013 Oct;37(5):619-24. doi: 10.1016/j.canep.2013.06.005. Epub 2013 Jul 11.

2.

Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, Hines L, Baumgartner KB, Giuliano AR, Wolff RK.

Int J Cancer. 2014 Feb 1;134(3):629-44. doi: 10.1002/ijc.28377. Epub 2013 Aug 9.

3.

Replication study for reported SNP associations with breast cancer survival.

Beeghly-Fadiel A, Zheng W, Lu W, Long J, Zheng Y, Cai H, Gu K, Chen Z, Cai Q, Gao YT, Shu XO.

J Cancer Res Clin Oncol. 2012 Jun;138(6):1019-26. doi: 10.1007/s00432-012-1174-6. Epub 2012 Feb 25.

4.

Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.

Bao PP, Zhao ZG, Gao YT, Zheng Y, Zhang B, Cai H, Zheng W, Shu XO, Lu W.

PLoS One. 2015 Feb 13;10(2):e0117419. doi: 10.1371/journal.pone.0117419. eCollection 2015.

5.

Association of interleukin-10 gene variation with breast cancer prognosis.

Gerger A, Renner W, Langsenlehner T, Hofmann G, Knechtel G, Szkandera J, Samonigg H, Krippl P, Langsenlehner U.

Breast Cancer Res Treat. 2010 Feb;119(3):701-5. doi: 10.1007/s10549-009-0417-y. Epub 2009 May 13.

PMID:
19437115
6.

Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Slattery ML, Herrick JS, Torres-Mejia G, John EM, Giuliano AR, Hines LM, Stern MC, Baumgartner KB, Presson AP, Wolff RK.

Carcinogenesis. 2014 Aug;35(8):1750-9. doi: 10.1093/carcin/bgu078. Epub 2014 Mar 26.

7.

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Makhoul I, Todorova VK, Siegel ER, Erickson SW, Dhakal I, Raj VR, Lee JY, Orloff MS, Griffin RJ, Henry-Tillman RS, Klimberg S, Hutchins LF, Kadlubar SA.

PLoS One. 2017 Jan 3;12(1):e0168550. doi: 10.1371/journal.pone.0168550. eCollection 2017.

8.

Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study.

Georgiou GK, Igglezou M, Sainis I, Vareli K, Batsis H, Briasoulis E, Fatouros M.

World J Surg Oncol. 2013 Aug 27;11:213. doi: 10.1186/1477-7819-11-213.

9.

Association of polymorphisms of angiogenesis genes with breast cancer.

Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, Skaar T, Flockhart DA.

Breast Cancer Res Treat. 2008 Sep;111(1):157-63. Epub 2007 Sep 20.

PMID:
17891484
10.

Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.

Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD.

Clin Cancer Res. 2009 Mar 15;15(6):2181-91. doi: 10.1158/1078-0432.CCR-08-0716. Epub 2009 Mar 10.

11.

VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.

Slattery ML, Lundgreen A, Wolff RK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E140-50. doi: 10.1002/mc.22058. Epub 2013 Jun 21.

PMID:
23794399
12.

The influence of functional polymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients in a Chinese population.

Fu F, Wang C, Chen LM, Huang M, Huang HG.

DNA Cell Biol. 2013 May;32(5):274-82. doi: 10.1089/dna.2012.1928. Epub 2013 Apr 9.

PMID:
23570558
13.

Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Beeghly-Fadiel A, Shu XO, Lu W, Long J, Cai Q, Xiang YB, Zheng Y, Zhao Z, Gu K, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):33-41. doi: 10.1158/1055-9965.EPI-10-0793. Epub 2010 Nov 30.

14.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

15.

Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.

Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G, Lenner P, Hemminki K.

Breast Cancer Res Treat. 2007 Jan;101(1):83-93. Epub 2006 Jun 29.

PMID:
16807673
16.

Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer.

Murray JL, Thompson P, Yoo SY, Do KA, Pande M, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM.

Breast Cancer Res Treat. 2013 Apr;138(3):917-24. doi: 10.1007/s10549-013-2445-x. Epub 2013 Mar 26.

17.

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG.

Carcinogenesis. 2010 Mar;31(3):455-61. doi: 10.1093/carcin/bgp307. Epub 2009 Dec 4.

18.

Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival.

Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6037-42.

19.

Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK.

PLoS One. 2013 May 16;8(5):e63165. doi: 10.1371/journal.pone.0063165. Print 2013.

20.

Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.

Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, Zheng W.

Breast Cancer Res Treat. 2007 Sep;104(3):309-19. Epub 2006 Oct 25.

PMID:
17063263

Supplemental Content

Support Center